Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)

Department of Health and Human Services National Institutes of Health
Tipo

Research/project funding

Posted on

Scadenza delle domande

Reference Number

PAR-23-258

The goal of this Notice of Funding Opportunity (NOFO) is to accelerate the establishment ofeffective and reliable biomarkers of Alzheimers disease (AD) and AD-related dementias (ADRD) for usein therapy/medical product discovery and development, clinical trials and/or clinical practice. Specifically, this NOFO willsupport analytical and/or clinical validationof a biomarker, composite biomarker or biomarker signature, withrigor comparable with the expectations described in the Food and Drug Administration (FDA)Biomarker Qualification Program (BQP) or recommended by other FDA regulatory pathways.
Categories: Health.

More Information

Visit Website

Tipo

Research/project funding

Posted on

Scadenza delle domande

Reference Number

PAR-23-258

, Stati Uniti